Supplement: Cancer Immunotherapies Development Barriers – Genetic Engineering & Biotechnology News
|
Supplement: Cancer Immunotherapies Development Barriers
Genetic Engineering & Biotechnology News Over the past century, a greater understanding of how our immune system recognizes and targets foreign invaders for destruction has emerged, resulting in cancer immunotherapy breakthroughs. Today, more than 900 immunotherapy agents are in clinical … |
